APLS vs GWW · rev $1.00B vs P/E 27, rev $9.76B
Apellis Pharmaceuticals Inc (APLS) versus WW Grainger Inc (GWW) — a side-by-side from cached financials, not a winner call.
Apellis Pharmaceuticals Inc (APLS) is a biotechnology company listed on US.
WW Grainger Inc (GWW) is a industrial distribution company listed on US.
Latest reported APLS revenue for 2025-12-31 was $1.00B. Net income was $22.4M. Revenue was up 28.5% from 2024-12-31 to 2025-12-31. APLS currently screens at market cap $2.29B.
Latest reported GWW revenue for 2026-06-30 was $9.76B. Net income was $1.13B. GWW currently screens at market cap $50.34B and trailing P/E 26.9.
APLS currently screens at market cap $2.29B. GWW currently screens at market cap $50.34B and trailing P/E 26.9.
Not investment advice. Open the APLS and GWW stock pages for the full models.
Not investment advice.